Raquel Juárez-Sánchez

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia

Carlos Cuesta‐Mateos, Patricia Fuentes, Alexandra Schrader et al. · Biomarker Research · 2020 · 29 citations · Full text

Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment

Ignacio Relaño-Rodríguez, Raquel Juárez-Sánchez, Carolina Pavicic et al. · Journal of Nanobiotechnology · 2019 · 25 citations · Full text

Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses

José M. Serra López-Matencio, Yaiza Pérez García, Virginia Meca‐Lallana et al. · Frontiers in Neurology · 2021 · 22 citations · Full text

Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL

Carlos Cuesta‐Mateos, Raquel Juárez-Sánchez, Tamara Mateu‐Albero et al. · mAbs · 2021 · 16 citations · Full text

Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody

Tamara Mateu‐Albero, Raquel Juárez-Sánchez, Javier Loscertales et al. · Cancer Immunology Immunotherapy · 2021 · 10 citations · Full text